openPR Logo
Press release

Canada Oncology Drugs Market Increase in Prevalence of Cancer, Rise in the Population, And Growth in Awareness about the Availability of Cancer Treatments Predominantly Drive the Market Growth

02-13-2019 11:02 AM CET | Health & Medicine

Press release from: Allied Market Research

Canada Oncology Drugs Market

Canada Oncology Drugs Market

Oncology drugs help prevent, diagnose and treat cancer. It uses chemotherapy drugs, hormone therapy drugs such as Tamoxifen (brand name Nolvadex), immunotherapy drugs, and other drugs such as bosulif (bosutinib), bosutinib, brentuximab vedotin and brigatinib for cancer. According to the CDC, 21.1 million adults were diagnosed with cancer in 2015. This suggests that the number of oncology drugs in the market needs to increase rapidly. In 2017, about 206,200 cancers (males and females) are expected to be diagnosed in Canada. Half of these (103,200) will include lung cancer, breast cancer, colorectal cancer, and prostate cancer.

Increased awareness of cancer epidemics, population growth, and the availability of cancer treatments is driving market growth. However, the high costs associated with the development of new drugs and the threat of side effects and side effects associated with anticancer treatment are expected to curb growth in the Canadian oncology drug market. Nonetheless, advances in cancer drug research due to biological / targeted therapies and tailor-made drugs provide promising opportunities for pharmaceutical, biopharmaceutical and biotechnology companies engaged in cancer drug development.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-toc-and-sample/2853

The companies operating in the market are
• AstraZeneca Plc.
• GlaxoSmithKline
• Eli lilly & Co.
• Roche diagnostics
• Novartis AG
• Pfizer Inc.
• Merck & Co.
• Gilead
• Sanofi S.A
• Celgene Corporation

The Canadian Oncology Drug Market is categorized by treatment type and cancer type. Depending on the type of treatment, the market is divided into chemotherapy, target therapy, immunotherapy (biotherapy), and hormonal therapy. Depending on the type of cancer, the market is classified as blood cancer, breast cancer, gastrointestinal cancer, respiratory / lung cancer, and skin cancer.

Make an Enquiry before Buy @ https://www.alliedmarketresearch.com/purchase-enquiry/2853

Key Benefits
• The study provides an in-depth analysis of the Canada oncology drugs market along with current trends and future estimations to elucidate the imminent investment pockets.
• It presents a quantitative analysis from 2016 to 2023 to enable the stakeholders to capitalize on prevailing market opportunities.
• Extensive analysis of the market by product type elucidates the various forms of available oncology drugs.
• Key players are profiled and their strategies are analyzed thoroughly to predict the competitive outlook of the market.
• The projections in this report are made by analyzing the current trends and future market potential from 2016 to 2023 in terms of value.

Access Full Summery @ https://www.alliedmarketresearch.com/canada-oncology-drugs-market

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Contact:

David Correa

5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States

Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975

help@alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Canada Oncology Drugs Market Increase in Prevalence of Cancer, Rise in the Population, And Growth in Awareness about the Availability of Cancer Treatments Predominantly Drive the Market Growth here

News-ID: 1584312 • Views: 269

More Releases from Allied Market Research

North America Geogrid Market 2020 Segmentation, Demand, Growth, Trend, Opportuni …
According to the report published by Allied Market Research, the North America geogrid market generated $282.0 million in 2019, and is estimated to reach $408.25 million by 2027, registering a CAGR of 7.0% from 2020 to 2027. The report offers an extensive analysis of changing market dynamics, key winning strategies, business performance, major segments, and competitive scenarios. Surge in infrastructure development activities across the U.S. and Mexico and superior physical properties
Intravenous Immunoglobulin (IVIG) Market 2020 In-Depth Analysis of Industry Shar …
Global intravenous immunoglobulin market accounted for $8,995 million in 2017, and is projected to reach $15,964 million by 2025, registering a CAGR of 7.5% from 2018 to 2025. Immunoglobulin (Ig) is a plasma-derived product, which is obtained from the serum of healthy donors. The isolated plasma product is clinically treated and purified to Ig, which can be further used in the treatment of patients with antibody deficiency. Intravenous immunoglobulin (IVIG) finds
Asthma and COPD Drugs Market Is Expected to Witness a Steady Growth by 2026
"Asthma and COPD Drugs Market by Disease and Medication Class - Global Opportunity Analysis and Industry Forecasts, 2014-2022", projects that the global market for Asthma and COPD Drugs was valued at $38,960 million in 2015 and would reach $50,359 million by 2022, registering a CAGR of 3.7% from 2016 to 2022. Asthma segment dominated the market in 2015 and expected to continue its dominance throughout the forecast period. North America
Synthetic Biology Market in Global Industry by Top Companies, Type and Applicati …
Global Synthetic biology market is forecast to reach $38.7 billion by 2020, at a CAGR of 44.2% during the forecast period (2014 - 2020). Europe occupies largest share in the global market and would hold-on to its position throughout 2020. However, Asia Pacific is the fastest growing market with a CAGR of 46.4% from 2014 - 2020. Read Full Report @ https://www.alliedmarketresearch.com/synthetic-biology-market Synthetic biology is at a nascent stage and has recently

All 5 Releases


More Releases for Canada

Employee Benefits in Canada 2018
The Canadian social security system covers various programs, many of which are run by the country's provinces and territories. In general, benefits are similar across all provinces and territories; however, Quebec implements its own pension plan. The government provides financial support to provincial and territorial governments through four main transfer programs-the Canada Health Transfer (CHT), the Canada Social Transfer (CST), and Equalization and Territorial Formula Financing (TFF)-to help them provide
CBF Management, Canada
'''CBF Management''' is the doing-business-as name of CBF Management/CBF and currently a non-franchisor selling and supporting post construction cleaning services, janitorial, commercial, residential, and floor care services through the [[Canada]], and 2 other countries using the “CBF Management” trademarks and systems to commercial services. Company History and Key Dates *2006 – CBF Management Company founded in Vancouver, British Columbia, as a floor care company by Harpreet Sandhu, a former track athlete. *2008 –
Jewellery Market in Canada
Summary This report helps to analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the Jewellery in Canada Market. Description Producers of fine jewellery brands continue to invest and expand across Canada, bringing more competition. In late 2016, David Yurman introduced its high jewellery collection at Holt Renfrew in Vancouver, featuring by-appointment-only pieces. It also aims to open more outlets in luxury
Medium & Heavy Trucks in Canada
ReportsWorldwide has announced the addition of a new report title Medium & Heavy Trucks in Canada to its growing collection of premium market research reports. Medium & Heavy Trucks in Canada industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the
Agrochemicals Market in Canada
ReportsWorldwide has announced the addition of a new report title Canada: Agrochemicals: Market Intelligence (2016-2021) to its growing collection of premium market research reports. The report “Canada: Agrochemicals: Market Intelligence (2016-2021)” provides market intelligence on the different market segments, based on type, active ingredient, formulation, crop, and pest. Market size and forecast (2016-2021) has been provided in terms of both, value (000 USD) and volume (000 KG) in the report. A
Consumer Payments Country Snapshot: Canada
ReportsWorldwide has announced the addition of a new report title Consumer Payments Country Snapshot: Canada 2016 to its growing collection of premium market research reports. In spite of being a highly mature market, Canada provides increasing opportunities for digital and mobile payment providers to develop innovation. Canada is a developed payment card market due to its robust economy and high level of card penetration. While the market has a high level